16. Segment Information

12 Months Ended

Dec. 31, 2012

Segment Reporting Disclosure [Text Block]

16. SEGMENT INFORMATION

The Company operates in one reportable segment—the research, development and sale of medical devices to diagnose skin cancer. The Company’s chief operating decision maker reviews financial information for the Company as a whole for purposes of allocating resources and evaluating financial performance. Substantially all long-lived assets of the Company are in the United States. Sales for each significant geographical area are as follows:

	Year Ended December 31,
	2012				2011
		Product Sales	Percent			Product Sales	Percent
		(in millions)				(in millions)
North America	$	0.5	23	%	$	0.6	16	%
Europe		1.0	39	%		1.3	41	%
Asia		0.6	25	%		1.0	32	%
Latin America		0.2	8	%		0.2	7	%
Australia		0.1	5	%		0.1	4	%
Total	$	2.4	100	%	$	3.2	100	%